Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Bromocriptine Mesylate Capsules USP, 5 mg (base) LEK USA, ANDA 75-100 BROMOCRIPTINE MESYLATE Capsule; 5MG BASE PARLODEL NOVARTIS 074631 BROMOCRIPTINE MESYLATE Tablet; 2.5MG BASE BROMOCRIPTINE MESYLATE LEK 017962 BROMOCRIPTINE MESYLATE Tablet; 2.5MG BASE PARLODEL NOVARTIS | Bromocriptine Mesylate Tablets, Mylan Pharma, Approval | Bromocriptine Mesylate Capsules, Mylan Pharma, Approval | Parlodel (bromocriptine mesylate), Novartis Pharma, Labeling Revision | Bromocriptine Mesylate Capsules, Zydus Pharmaceuticals USA, Inc., Approval | Bromocriptine Mesylate Tablets, Paddock Laboratories, Inc., Approval | Cycloset (bromocriptine mesylate) Tablets, VeroScience, LLC, Approval | Cycloset (bromocriptine mesylate) Tablets, VeroScience, LLC, Labeling Revision | Parlodel, bromocriptine mesylate, Capsule; Oral, Novartis, Labeling Revision | Parlodel, bromocriptine mesylate, Tablet; Oral, Novartis, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com